Navigation Links
Kaiser Permanente study shows link between caffeine and miscarriage
Date:1/20/2008

erall, 172 of women in the study (16.18 percent) miscarried. Whereas 264 women (25 percent) reported no consumption of any caffeine containing beverages during pregnancy, 635 women (60 percent) reported 0-200 mg of caffeine intake per day, and 164 women (15 percent) had 200 mg or more of daily caffeine consumption.

Critics had maintained that the association was not so much a high dose of caffeine intake that increased the risk of miscarriage, but that women with a healthy pregnancy are more likely (than those about to miscarry), to reduce their caffeine intake due to nausea, vomiting, and aversion to caffeine, Li said. Therefore, the critics claimed that the observed association was a result of reduction of caffeine intake by healthy pregnant women, he said.

So whats a fatigued mom-to-be supposed to do for her daily energy jolt?

If you definitely need caffeine to get you going, try keeping it to one cup or less a day. Avoiding it may be even better. Consider switching to decaffeinated coffee and other decaffeinated beverages during your pregnancy," said Tracy Flanagan, MD, Director of Women's Health, Kaiser Permanente Northern California. Learn to perk up instead with natural energy boosts like a brisk walk, yoga stretches, snacking on dried fruits and nuts.


'/>"/>

Contact: Danielle Cass
Danielle.X.Cass@kp.org
510-267-5354
Edelman Public Relations
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Kaiser Permanente Provides $1.4 Million in Holiday Gifts to 40 Metro Atlanta Nonprofits
2. Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
3. GDS / Denex Dental Selected by Kaiser Permanente Northwest
4. Kaiser Permanente and Discovery Health Team Up to Fight Childhood Obesity Epidemic
5. Kaiser Permanente Opens 15th Medical Facility in Georgia
6. Kaiser Permanente/Harvard Medical School study links lack of sleep to weight gain for new moms
7. Kaiser Permanente Recognized by NCQA for Innovative Program to Reduce Health Care Disparities
8. U.S. News & World Report Names Kaiser Permanente Top-Ranked Health Plan in Georgia
9. Kaiser Foundation Health Plan Earnings Support Investments in Member and Community Health
10. Kaiser Permanente Puts Personal Health Record Front and Center
11. Following Heart Disease Guidelines Saves Lives, According to a Kaiser Permanente Abstract Presented at AHA Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Consumers advised to avoid oysters harvested from San Antonio ... -- The U.S. Food and Drug Administration is advising ... Antonio Bay on or after Nov. 16 due to ... consumed oysters harvested from this area, which is located ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ,, The FDA, along with ...
(Date:12/6/2009)... a key segment of DNA can lead to severe childhood ... kind of genetic alteration can cause obesity. The results are ... by Dr Sadaf Farooqi from the University of Cambridge and ... at 300 children with severe obesity. , The team scanned ... as copy number variants (CNVs). CNVs are large chunks of ...
(Date:12/6/2009)... virus , , SUNDAY, Dec. 6 (HealthDay News) -- Early roots ... a tiger that lived thousands or millions of years ago, ... on a bit of a tiger,s genetic material, scientists say, ... to this day. That tiger, in fact, may have bitten ... ultimately led to its infection of humans. , The finding ...
(Date:12/6/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... 003-A1 study, known as the 003 trial, demonstrating ... and refractory multiple myeloma patients. These data were ... the 51st annual meeting of the American Society ... this trial is complete (n=269), and full results, ...
(Date:12/6/2009)... Blood clotting, or coagulation, is an ... blood vessel is injured. Sometimes, however, clots form ... injury or do not dissolve naturally, a potentially ... the 51st Annual Meeting of the American Society ... the anticoagulants aspirin and heparin with the hope ...
Breaking Medicine News(10 mins):Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:AIDS May Date Back to Ancient Tiger 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7
... CINCINNATI, Oct. 28 LCA-Vision Inc. (Nasdaq:,LCAV), a ... the,LasikPlus(R) brand, today announced that it will serve ... insurance benefit underwritten by a nationally,known, "A-" (Excellent) ... New York. The benefit provides members covered by,sponsoring ...
... provides "total eSolution" to clinical ... ... ECRFPlus, a software company,focused on developing web-based integrated clinical trials ... with specialty contract research organization (CRO) and ECG core,lab Spacelabs ...
... PROCEDURES, CHICAGO, Oct. 28 While history ... presidential candidates to the person,next door, the economic ... surgery plans. The results of consumer and plastic ... Surgery 2008, the,annual scientific meeting of the American ...
... Woodlands plastic surgery team, Dr. Bob Basu, MD, MPH, FACS and ... and performed the first DIEP free flap breast reconstruction procedure in The ... ... TX (PRWEB) October 28, 2008 -- Dr. Bob Basu and Dr. Sugene ...
... hemoglobin A1c monitoring market is forecast to surpass $272 million by ... population. Other growth drivers include greater glucose control and product innovations ... ... Jose, CA (PRWEB) October 28, 2008 -- World Health Organization forecasts ...
... provider, recently added "Protective Life Insurance Company," to their portfolio ... ... Irvine, CA (PRWEB) October 28, 2008 -- TheHealthQuote continues to ... their current portfolio of top rated insurance companies - which ...
Other Medicine News:Health News:LCA-Vision Named Provider for New Insured Lasik Product 2Health News:LCA-Vision Named Provider for New Insured Lasik Product 3Health News:LCA-Vision Named Provider for New Insured Lasik Product 4Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 2Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 3Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 4Health News:Consumers and Plastic Surgeons Say Economy Is Cutting Into Cosmetic Procedures 2Health News:Consumers and Plastic Surgeons Say Economy Is Cutting Into Cosmetic Procedures 3Health News:Plastic Surgery Team Pioneered the First DIEP Free Flap Breast Reconstruction in The Woodlands, Texas 2Health News:Plastic Surgery Team Pioneered the First DIEP Free Flap Breast Reconstruction in The Woodlands, Texas 3Health News:Plastic Surgery Team Pioneered the First DIEP Free Flap Breast Reconstruction in The Woodlands, Texas 4Health News:Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc. 2Health News:Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc. 3Health News:Esteemed Medical and Life Insurance Provider Adds to Their List of Top-Rated Insurance Options 2Health News:Esteemed Medical and Life Insurance Provider Adds to Their List of Top-Rated Insurance Options 3
(Date:12/4/2009)... $2.8 million, four-year federal grant will support researchers at ... collaborators at Wake Forest University as they study why ... and how to address the problem. This "storage lesion," ... risk for cardiovascular events and organ failure, particularly among ...
(Date:12/4/2009)... Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, ... related amended Disclosure Statement with the United States Bankruptcy Court ... to consider the adequacy of the Disclosure Statement is presently ... confirmation of the Plan scheduled for January 7, 2010. ,, ...
(Date:12/4/2009)... (OTC Bulletin Board: OXBT) today announced that the first ... dose escalation, clinical trial in Switzerland for use of ... the Company,s perfluorocarbon (PFC) therapeutic oxygen carrier. ,, "This ... of patients with severe TBI. We hope to finally ...
Breaking Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2UCI researchers create new strategy for highly selective chemotherapy delivery 58290 1UCI researchers create new strategy for highly selective chemotherapy delivery 58290 2Siebel Foundation awards top UC San Diego bioengineering graduate students 10098 1Siebel Foundation awards top UC San Diego bioengineering graduate students 10098 2Siebel Foundation awards top UC San Diego bioengineering graduate students 10098 3Siebel Foundation awards top UC San Diego bioengineering graduate students 10098 4Nanoparticle based battlefield pain treatment moves a step closer 10094 1Nanoparticle based battlefield pain treatment moves a step closer 10094 2
... WIRE)--July 8, 2007 - Cougar Biotechnology,Inc. (OTCBB:CGRB) today ... on the Company's prostate cancer drug candidate CB7630,(abiraterone ... Oncology (ESMO) Conference, which is currently taking place,in ... oral and,poster presentations on Sunday, July 8, as ...
... Positive Phase IIa Clinical,Trial Results, First clinical ... in AM-Pharma's Pipeline , BUNNIK, The Netherlands, ... novel therapeutics to treat,infectious and inflammatory diseases, ... Phase IIa Alkaline Phosphatase (AP) trial,for patients ...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 6AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
... Para 12 Plus is a hematology control ... 3500/3700. Assay values are provided for the ... a three-part differential on the CELL-DYN 1600 ... and closed-vial stability is 75 days. Para ...
Indicated to facilitate the intra-luminal placement of conventional guidewires beyond stenotic lesions, including chronic total coronary occlusions....
... 5X is a whole blood hematology control ... 80 and 120, and the Coulter AcT5diff ... a unique white cell differential, positioning the ... on the systems. The product offers 105-day ...
Medicine Products: